Characterization of a novel anti-human lymphocyte activation gene 3 (LAG-3) antibody for cancer immunotherapy
Yu, Xiaojie, Huang, Xiao, Chen, Xiuxiu, Liu, Jianfei, Wu, Chenglin, Pu, Qian, Wang, Yuxiao, Kang, Xiaoqiang, Zhou, Lijun
Published in mAbs (18.08.2019)
Published in mAbs (18.08.2019)
Get full text
Journal Article
Monoclonal Antibody Cetuximab Binds to and Down-regulates Constitutively Activated Epidermal Growth Factor Receptor vIII on the Cell Surface
PATEL, Dipa, LAHIJI, Armin, PATEL, Sheetal, FRANKLIN, Matthew, JIMENEZ, Xenia, HICKLIN, Daniel J, XIAOQIANG KANG
Published in Anticancer research (01.09.2007)
Get full text
Published in Anticancer research (01.09.2007)
Journal Article
841 LBL-019, a novel TNFR2 agonist antibody, shows potent anti-tumor efficacy through preferentially activating CD8+ T cells and alleviating the suppressive effect of Treg cells
Wang, Baohui, Wang, Hailin, Li, Tingting, Sun, Jianming, Huang, Xiao, Lin, Huan, Dan, Yujia, Qin, Yurong, Zhang, Peng, Guan, Jing, Wu, Guojin, Hou, Xiaofan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
A Fully Human Recombinant IgG-like Bispecific Antibody to Both the Epidermal Growth Factor Receptor and the Insulin-like Growth Factor Receptor for Enhanced Antitumor Activity
Lu, Dan, Zhang, Haifan, Koo, Henry, Tonra, James, Balderes, Paul, Prewett, Marie, Corcoran, Eric, Mangalampalli, Venkata, Bassi, Rajiv, Anselma, Deborah, Patel, Dipa, Kang, Xiaoqiang, Ludwig, Dale L., Hicklin, Daniel J., Bohlen, Peter, Witte, Larry, Zhu, Zhenping
Published in The Journal of biological chemistry (20.05.2005)
Published in The Journal of biological chemistry (20.05.2005)
Get full text
Journal Article
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation
PATEL, Dipa, BASSI, Rajiv, HOOPER, Andrea, PREWETT, Marie, HICKLIN, Daniel J, XIAOQIANG KANG
Published in International journal of oncology (01.01.2009)
Published in International journal of oncology (01.01.2009)
Get full text
Journal Article
Enhanced Suppression of Melanoma Tumor Growth and Metastasis by Combined Therapy with Anti-VEGF Receptor and Anti-TYRP-1/gp75 Monoclonal Antibodies
PATEL, Dipa, BASSI, Rajiv, HOOPER, Andrea T, HAIJUN SUN, HUBER, James, HICKLIN, Daniel J, XIAOQIANG KANG
Published in Anticancer research (01.09.2008)
Get full text
Published in Anticancer research (01.09.2008)
Journal Article
The use of melanosomal proteins in the immunotherapy of melanoma
Kawakami, Y, Robbins, P F, Wang, R F, Parkhurst, M, Kang, X, Rosenberg, S A
Published in Journal of immunotherapy (1997) (01.07.1998)
Published in Journal of immunotherapy (1997) (01.07.1998)
Get more information
Journal Article
Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model
Huang, Xiao, Sun, Jianming, Qin, Yurong, Lin, Huan, Guan, Jing, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
Abstract 1791: LBL-015, a novel anti-PD-1 fused with TGF-βRII, shows a great anti-tumor activity in a mouse MC38 model
Huang, Xiao, Sun, Jianming, Qin, Yurong, Lin, Huan, Guan, Jing, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
The high-affinity human IgG receptor FcγRI (CD64) promotes IgG-mediated inflammation, anaphylaxis, and antitumor immunotherapy
Mancardi, David A., Albanesi, Marcello, Jönsson, Friederike, Iannascoli, Bruno, Van Rooijen, Nico, Kang, Xiaoqiang, England, Patrick, Daëron, Marc, Bruhns, Pierre
Published in Blood (28.02.2013)
Published in Blood (28.02.2013)
Get full text
Journal Article
Lbl-034, a Highly Differentiated T-Cell Engaging Bispecific Antibody Targeting GPRC5D for the Treatment of Relapsed or Refractory Multiple Myeloma
Wang, Baohui, Huang, Xiao, Sun, Jianming, Qin, Yurong, Shang, Hongyan, Li, Tingting, Wu, Guojin, Chen, Min, Wang, Hailin, Zhang, Peng, Jiang, Duqing, Liu, Tongjun, Ye, Mi, Cai, Shengli, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Abstract 1867: LBL-049: A novel neutralizing antibody against GDF15 for the treatment of cachexia
Wang, Baohui, Huang, Xiao, Ding, Mi, Huang, Jing, Qin, Yurong, Li, Fengxia, Guan, Jing, Sun, Jianming, Wu, Guojin, Liu, Xiaoxiao, Zhu, Jordan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract 5523: LBL-019, a novel anti-TNFR2 antibody, shows a potent anti-tumor efficacy in a mouse MC38 model
Lin, Huan, Huang, Xiao, Qin, Yurong, Dang, Yujia, Zhang, Peng, Sun, Jianming, Guan, Jing, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract 2965: LBL-033, a novel bispecific antibody targeting MUC16 and CD3, for the treatment of tumors over-expressing MUC16
Sun, Jianming, Huang, Xiao, Qin, Yurong, Fang, XingXing, Chen, Min, Lin, Huan, Guan, Jing, Huang, Jing, Liu, Tongjun, Wang, Baohui, Wu, Guojin, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Published in Cancer research (Chicago, Ill.) (04.04.2023)
Get full text
Journal Article
Abstract 6712: LBL-043, a novel LILRB4xCD3 T cell engager, for the treatment of LILRB4 positive leukemia
Dang, Yujia, Huang, Xiao, Qin, Yurong, Liu, Xiaoya, Chen, Min, Jiang, Duqing, Wu, Guojin, Ye, Mi, Sun, Jianming, Wang, Baohui, Guan, Jing, Li, Tingting, Zhu, Jordan, Lai, Shoupeng, Kang, Xiaoqiang, Ling, Hong
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab
Patel, Dipa, Guo, Xuemei, Ng, Stanley, Melchior, Maxine, Balderes, Paul, Burtrum, Douglas, Persaud, Kris, Luna, Xenia, Ludwig, Dale L., Kang, Xiaoqiang
Published in Human antibodies (2010)
Published in Human antibodies (2010)
Get full text
Journal Article